CAM
NVO

Chesapeake Asset Management’s Novo Nordisk NVO Stock Holding History

Chesapeake Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-156
Closed -$10.8K – 473
2025
Q1 		$10.8K Hold
156
– – 0.01% 199
2024
Q4 		$13.4K Hold
156
– – 0.01% 189
2024
Q3 		$18.6K Hold
156
– – 0.02% 175
2024
Q2 		$22.3K Hold
156
– – 0.02% 159
2024
Q1 		$20K Hold
156
– – 0.02% 163
2023
Q4 		$16.1K Hold
156
– – 0.01% 204
2023
Q3 		$14.2K Buy
+156
New +$13.7K 0.01% 220

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Chesapeake Asset Management's NVO Position: Q2 2025 in Review

Chesapeake Asset Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 156 shares — an estimated $10.8K sold.

Chesapeake Asset Management first reported a position in NVO in Q3 2023 and held it in 7 quarters. The position peaked at $22.3K in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Chesapeake Asset Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 156 Novo Nordisk shares in Q2 2025, an estimated $10.8K.
  • Chesapeake Asset Management first reported a position in Novo Nordisk in Q3 2023 and held it in 7 quarters.
  • Chesapeake Asset Management's Novo Nordisk position peaked at $22.3K in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Chesapeake Asset Management's 13F filing for Q2 2025, filed 15 Oct 2025.